Full Text
EE324 Developing the Next Generation of Therapeutics: The Role of Early Model-Based Cost-Effectiveness Analysis

Abstract

Authors

Fanyi Su Sean P. Gavan Maya Buch Katherine Payne

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×